Tertiary lymphoid structures (TLSs)—immune-cell aggregates that form in many solid tumours—have been linked to better outcomes from immune checkpoint blockade....

A new study highlights how a little-known protein, OTUB1, can reshape cell death pathways in hepatocellular carcinoma (HCC). Researchers report...

In papillary thyroid carcinoma (PTC), cancer progression is increasingly understood as a product of two intertwined signaling engines: MAPK and...

Viral Science News reports a new clinical study exploring an urgently needed option for young patients facing chemotherapy-induced thrombocytopenia (CIT)....

Scientists have uncovered direct evidence that inherited genetics can steer how cancers emerge and evolve, even after the same environmental...

Viral CAR-T cell therapy has transformed treatment options for aggressive blood cancers, yet its benefits and risks vary widely among...

Tumor-killing T cells can be remarkably potent, yet in ovarian cancer they often fail to mount effective responses. A new...

HDAC6, a cytoplasmic deacetylase best known for shaping cell stress responses, is emerging as an unusually informative flag in blood...

A new study from researchers in 2026 reports that tumor progression can disrupt ovarian function even when tumors are not...

In leukemia’s most aggressive settings, bone marrow–resident blood-cell factories fail to complete normal maturation. Instead of rapidly generating mature immune...